REGIONAL HEMODYNAMIC-EFFECTS OF PLATELET-ACTIVATING-FACTOR IN THE RAT

被引:7
作者
KING, KA [1 ]
LIM, SL [1 ]
PANG, CCY [1 ]
机构
[1] UNIV BRITISH COLUMBIA,FAC MED,DEPT PHARMACOL & THERAPEUT,VANCOUVER,BC V6T 1Z3,CANADA
关键词
PAF (PLATELET ACTIVATING FACTOR); HEMODYNAMICS; BLOOD FLOW; REGIONAL; PAF RECEPTOR ANTAGONIST; MICROSPHERE;
D O I
10.1016/0014-2999(95)00243-E
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of platelet activating factor (PAF) on haemodynamics in the absence and presence of the potent PAF receptor antagonist TCV-309 (3-bromo-5-[N-phenyl-N-[2-[[2-(1,2,3,4-tetrahydro-2-isoquinolyl-carbonyloxy)ethyl]carbonamoyl]ethyl]carbamoyl]-1-propylpyridinium nitrate) were studied by the microsphere technique in pentobarbitone-anaesthetized rats. I.v. infusion of the low dose PAF (0.05 mu g kg(-1) min(-1)) did not significantly alter mean arterial pressure, cardiac output or total peripheral resistance but increased arterial conductances in the stomach, intestine, caecum and colon and reduced conductance in the spleen. I.v. infusion of the high dose of PAF (0.3 mu g kg(-1) min(-1)) markedly reduced mean arterial pressure (-53 mm Hg) and cardiac output (-62%) and insignificantly increased total peripheral resistance. Arterial conductances in the lungs, stomach, intestine, caecum and colon, kidneys and spleen were reduced and those in the heart and muscle were increased. TCV-309 (10 mu g kg(-1)) abolished all changes in arterial pressure, cardiac output and total peripheral resistance and arterial conductances elicited by either the low or the high dose of PAF. The results show that a non-hypotensive dose of PAF caused vasodilatation of the gastrointestinal organs and vasoconstriction of the spleen. A high dose of PAF which markedly decreased arterial pressure and cardiac output caused vasodilatation of the heart and muscle and vasoconstriction of the lungs (bronchial), gastrointestinal organs, kidneys and spleen. All haemodynamic changes were blocked by TCV-309 indicating the involvement of PAF receptors.
引用
收藏
页码:187 / 193
页数:7
相关论文
共 17 条
[1]  
BELIAN JA, 1992, AM J PHYSIOL, V263, P234
[2]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[3]   EFFECTS OF PHOSPHOLIPIDS ON RENAL-FUNCTION [J].
BUCKALEW, VM ;
STRANDHOY, JW ;
HANDA, RK .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 22 :S79-S81
[4]  
CHIBA Y, 1990, N-S ARCH PHARMACOL, V341, P68
[5]   EFFECT OF PLATELET ACTIVATING FACTOR (PAF) ON BLOOD-FLOW DISTRIBUTION IN THE SPONTANEOUSLY HYPERTENSIVE RAT [J].
GOLDSTEIN, BM ;
GABEL, RA ;
HUGGINS, FJ ;
CERVONI, P ;
CRANDALL, DL .
LIFE SCIENCES, 1984, 35 (13) :1373-1378
[6]  
GREENWAY CV, 1982, PHARMACOL REV, V33, P213
[7]   SELECTIVE-INHIBITION OF VASOCONSTRICTOR RESPONSES BY PLATELET-ACTIVATING-FACTOR IN RAT-KIDNEY [J].
HANDA, RK ;
STRANDHOY, JW ;
BUCKALEW, VM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1991, 261 (01) :F108-F116
[8]   DIFFERENTIAL ACTIONS OF PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONISTS ON THE VASODILATOR AND VASOCONSTRICTOR EFFECTS OF PAF IN THE RAT PERFUSED HEART [J].
HU, WM ;
MAN, RYK .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (04) :773-775
[9]   MECHANISMS OF THE CORONARY VASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR IN THE RAT PERFUSED HEART [J].
HU, WM ;
KINNAIRD, AAA ;
MAN, RYK .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) :1097-1102
[10]   ENDOTHELIUM-DEPENDENT VASODILATOR EFFECTS OF PLATELET ACTIVATING FACTOR ON RAT RESISTANCE VESSELS [J].
KAMATA, K ;
MORI, T ;
SHIGENOBU, K ;
KASUYA, Y .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 98 (04) :1360-1364